Gene Therapy Equity in Sickle Cell Disease: Distributional Cost-Effectiveness Analysis (DCEA) of Gene Therapy Vs. Standard-of-Care in Patients with Sickle Cell Disease in the United States

被引：2
|
作者：
Goshua, George [1 ]
Calhoun, Cecelia [1 ]
Cheng, Vivien [2 ]
James, Lyndon [2 ]
Luviano, Andrea [2 ]
Krishnamurti, Lakshmanan [3 ]
Pandya, Ankur [2 ]
机构：
[1] Yale Univ, Sch Med, Sect Hematol, New Haven, CT USA
[2] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA
[3] Yale Sch Med, Sect Pediat Hematol Oncol BMT, New Haven, CT USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-157460
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1395 / 1396
页数：2
相关论文
共 50 条
  • [1] Allotransplantation and Gene Therapy Equity for Children with Sickle Cell Disease: Distributional Cost- Effectiveness of Allotransplantation Vs Gene Therapy Vs Standard-of-Care in Pediatric Patients with Sickle Cell Disease in the United States
    Goshua, George
    Ito, Satoko
    Chetlapalli, Karthik
    Potnis, Kunal C.
    Calhoun, Cecelia
    Krishnamurti, Lakshmanan
    Krumholz, Harlan M.
    Pandya, Ankur
    [J]. BLOOD, 2023, 142
  • [2] Distributional Cost-Effectiveness of Equity-Enhancing Gene Therapy in Sickle Cell Disease in the United States
    Goshua, George
    Calhoun, Cecelia
    Ito, Satoko
    James, Lyndon P.
    Luviano, Andrea
    Krishnamurti, Lakshmanan
    Pandya, Ankur
    [J]. ANNALS OF INTERNAL MEDICINE, 2023, 176 (06) : 779 - +
  • [3] Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States A Cost-Effectiveness Analysis
    Basu, Anirban
    Winn, Aaron N.
    Johnson, Kate M.
    Jiao, Boshen
    Devine, Beth
    Hankins, Jane S.
    Arnold, Staci D.
    Bender, M. A.
    Ramsey, Scott D.
    [J]. ANNALS OF INTERNAL MEDICINE, 2024, 177 (02) : 155 - 164
  • [4] Cost-effectiveness of a hypothetical cell or gene therapy cure for sickle cell disease
    Jonathan Salcedo
    Jenniffer Bulovic
    Colin M. Young
    [J]. Scientific Reports, 11
  • [5] Cost-effectiveness of a hypothetical cell or gene therapy cure for sickle cell disease
    Salcedo, Jonathan
    Bulovic, Jenniffer
    Young, Colin M.
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [6] Gene therapy for sickle cell disease
    Olowoyeye, Abiola
    Okwundu, Charles I.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (08):
  • [7] Gene therapy for sickle cell disease
    不详
    [J]. LANCET HAEMATOLOGY, 2016, 3 (10): : E446 - E446
  • [8] Gene therapy in Sickle Cell disease
    Ribeil, Jean-Antoine
    Blanche, Stephane
    Cavazzana, Marina
    [J]. M S-MEDECINE SCIENCES, 2017, 33 (05): : 463 - 465
  • [9] Gene therapy for sickle cell disease
    Olowoyeye, Abiola
    Okwundu, Charles I.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (11):
  • [10] Gene therapy for sickle cell disease
    Leonard, Alexis
    Tisdale, John F.
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2023, (01) : 542 - 547
12345